Zasocitinib Landmark Ph3 Plaque Psoriasis Data Show Promise To Deliver Clear Skin
18/12/2025 08:01
Takeda Pharmaceutical Co Ltd 4502.T: TAKEDA PHARMACEUTICAL CO LTD - ZASOCITINIB LANDMARK PH3 PLAQUE PSORIASIS DATA SHOW PROMISE TO DELIVER CLEAR SKIN Source text: ID:nTSxr7f810 Further company coverage: 4502.T
Recent news on Takeda Pharmaceutical
See all newsTakeda launches sleep disorder pill in the US after DEA clearance removes final hurdle (updated)
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)